RESUMO
OBJECTIVE: To provide a portrait of gender affirmation surgery (GAS) insurance coverage across the United States, with attention to procedures of the head and neck. STUDY DESIGN: Systematic review. SETTING: Policy review of US medical insurance companies. METHODS: State policies on transgender care for Medicaid insurance providers were collected for all 50 states. Each state's policy on GAS and facial gender affirmation surgery (FGAS) was examined. The largest medical insurance companies in the United States were identified using the National Association of Insurance Commissioners Market Share report. Policies of the top 49 primary commercial medical insurance companies were examined. RESULTS: Medicaid policy reviews found that 18 states offer some level of gender-affirming coverage for their patients, but only 3 include FGAS (17%). Thirteen states prohibit Medicaid coverage of all transgender surgery, and 19 states have no published gender-affirming medical care coverage policy. Ninety-two percent of commercial medical insurance providers had a published policy on GAS coverage. Genital reconstruction was described as a medically necessary aspect of transgender care in 100% of the commercial policies reviewed. Ninety-three percent discussed coverage of FGAS, but 51% considered these procedures cosmetic. Thyroid chondroplasty (20%) was the most commonly covered FGAS procedure. Mandibular and frontal bone contouring, rhinoplasty, blepharoplasty, and facial rhytidectomy were each covered by 13% of the medical policies reviewed. CONCLUSION: While certain surgical aspects of gender-affirming medical care are nearly ubiquitously covered by commercial insurance providers, FGAS is considered cosmetic by most Medicaid and commercial insurance providers, potentially limiting patient access. LEVEL OF EVIDENCE: Level V.
Assuntos
Face/cirurgia , Cobertura do Seguro , Seguro Saúde , Medicaid , Cirurgia de Readequação Sexual/economia , Pessoas Transgênero , Feminino , Política de Saúde , Humanos , Masculino , Cirurgia de Readequação Sexual/normas , Governo Estadual , Estados UnidosRESUMO
Transgender and gender diverse (TGD) individuals face significant barriers to accessing health care. Recent introductions of regulatory policies at state and federal levels raise concerns over the politicization of gender-affirming health care, the risks of further restricting access to quality care, and the potential criminalization of healthcare professionals who care for TGD patients. The Endocrine Society and the Pediatric Endocrine Society have published several news articles and comments in the last couple of years supporting safe and effective gender-affirming interventions as outlined in the 2017 Endocrine Society's Clinical Practice Guidelines. The Endocrine Society Position Statement on Transgender Health also acknowledges the rapid expansion in understanding the biological underpinning of gender identity and the need for increased funding to help close gaps in knowledge about the optimal care of TGD individuals. This Policy Perspective affirms these principles in the context of pending and future legislation attempting to discriminate against TGD patients while also stressing the need for science and health care experts to inform health policies.
Assuntos
Atenção à Saúde/legislação & jurisprudência , Disparidades em Assistência à Saúde/normas , Pessoas Transgênero/legislação & jurisprudência , Feminino , Humanos , MasculinoAssuntos
Pessoal de Saúde/educação , Acessibilidade aos Serviços de Saúde , Disparidades em Assistência à Saúde , Qualidade da Assistência à Saúde , Pessoas Transgênero , Status Econômico , Registros Eletrônicos de Saúde , Humanos , Cobertura do Seguro , Patient Protection and Affordable Care Act , Pobreza , Guias de Prática Clínica como Assunto , Melhoria de Qualidade , Minorias Sexuais e de Gênero , Estados UnidosRESUMO
Transgender persons are a diverse group whose gender identity differs from their sex recorded at birth. Some choose to undergo medical treatment to align their physical appearance with their gender identity. Barriers to accessing appropriate and culturally competent care contribute to health disparities in transgender persons, such as increased rates of certain types of cancer, substance abuse, mental health conditions, infections, and chronic diseases. Thus, it is important that clinicians understand the specific medical issues that are relevant to this population.
Assuntos
Atenção Primária à Saúde/métodos , Pessoas Transgênero , Transexualidade/terapia , Confidencialidade , Aconselhamento , Estrogênios/efeitos adversos , Estrogênios/uso terapêutico , Ética Médica , Fertilidade , Infecções por HIV/prevenção & controle , Humanos , Monitorização Fisiológica , Educação de Pacientes como Assunto , Papel do Médico , Puberdade , Encaminhamento e Consulta , Procedimentos de Readequação Sexual , Terminologia como Assunto , Testosterona/efeitos adversos , Testosterona/uso terapêutico , Pessoas Transgênero/classificação , Pessoas Transgênero/legislação & jurisprudência , Pessoas Transgênero/psicologia , Transexualidade/classificação , Transexualidade/psicologiaRESUMO
OBJECTIVE: Transgender individuals now have many options for medical intervention, including gender-affirmation surgeries. However, it is unknown how common it is for transgender individuals to undergo these surgeries. The purpose of this cross-sectional study was to assess the prevalence of gender-affirming surgeries among transgender patients in 2015, which was immediately prior to insurance changes that made gender-affirming surgery more affordable for Massachusetts residents. METHODS: A retrospective chart review of 99 transgender patients was performed at the Endocrinology Clinic at Boston Medical Center, an urban safety net hospital. The records for 99 transgender subjects who received treatment between 2004-2015, including 28 transmen and 71 transwomen, were examined. The outcome measures were the types of medical interventions chosen by transgender patients, which included hormone therapy, chest surgery, gonadectomy, genital surgery, and facial surgery. RESULTS: Thirty-five percent of subjects had undergone at least one gender-affirming surgery. Transmen were more likely to have had surgery than transwomen (54% vs. 28%). Twenty-five percent of patients had chest surgery, 13% had genital surgery or gonadectomy, and 8% had facial surgery. CONCLUSION: In 2015, a majority of transgender endocrinology clinic patients had not undergone any type of gender-affirmation surgery. Among those who did elect to have a surgery, genital surgery or gonadectomy were uncommon. The low rate of surgery among this sample of transgender patients may be attributable to the financial cost, lack of interest in surgery, or that genital surgery is not a high priority for transgender individuals relative to surgery to change visible features such as face and chest. Abbreviation: HT = hormone therapy.
Assuntos
Cobertura do Seguro , Seguro Saúde , Procedimentos de Readequação Sexual/estatística & dados numéricos , Pessoas Transgênero , Adulto , Idoso , Implante Mamário/estatística & dados numéricos , Estudos Transversais , Feminino , Humanos , Histerectomia/estatística & dados numéricos , Masculino , Mamoplastia/estatística & dados numéricos , Pessoa de Meia-Idade , Orquiectomia/estatística & dados numéricos , Ovariectomia/estatística & dados numéricos , Implante Peniano/estatística & dados numéricos , Estudos Retrospectivos , Salpingectomia/estatística & dados numéricos , Adulto JovemAssuntos
Pesquisa Biomédica/tendências , Atenção à Saúde , Disparidades nos Níveis de Saúde , Disparidades em Assistência à Saúde , Grupos Minoritários , Saúde das Minorias , Pessoas Transgênero , Transexualidade/terapia , Conferências de Consenso como Assunto , Feminino , Prioridades em Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Masculino , Grupos Minoritários/psicologia , Avaliação das Necessidades , Procedimentos de Readequação Sexual , Pessoas Transgênero/psicologia , Transexualidade/psicologiaRESUMO
PURPOSE OF REVIEW: Transgender persons suffer significant health disparities and may require medical intervention as part of their care. The purpose of this manuscript is to briefly review the literature characterizing barriers to healthcare for transgender individuals and to propose research priorities to understand mechanisms of those barriers and interventions to overcome them. RECENT FINDINGS: Current research emphasizes sexual minorities' self-report of barriers, rather than using direct methods. The biggest barrier to healthcare reported by transgender individuals is lack of access because of lack of providers who are sufficiently knowledgeable on the topic. Other barriers include: financial barriers, discrimination, lack of cultural competence by providers, health systems barriers, and socioeconomic barriers. SUMMARY: National research priorities should include rigorous determination of the capacity of the US healthcare system to provide adequate care for transgender individuals. Studies should determine knowledge and biases of the medical workforce across the spectrum of medical training with regard to transgender medical care; adequacy of sufficient providers for the care required, larger social structural barriers, and status of a framework to pay for appropriate care. As well, studies should propose and validate potential solutions to address identified gaps.
Assuntos
Atenção à Saúde , Disparidades nos Níveis de Saúde , Disparidades em Assistência à Saúde , Grupos Minoritários , Saúde das Minorias , Pessoas Transgênero , Transexualidade/terapia , Feminino , Prioridades em Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Masculino , Grupos Minoritários/psicologia , Avaliação das Necessidades , Procedimentos de Readequação Sexual , Pessoas Transgênero/psicologia , Transexualidade/psicologiaRESUMO
PURPOSE OF REVIEW: This article describes methodological challenges, gaps, and opportunities in US transgender health research. RECENT FINDINGS: Lack of large prospective observational studies and intervention trials, limited data on risks and benefits of sex affirmation (e.g., hormones and surgical interventions), and inconsistent use of definitions across studies hinder evidence-based care for transgender people. Systematic high-quality observational and intervention-testing studies may be carried out using several approaches, including general population-based, health systems-based, clinic-based, venue-based, and hybrid designs. Each of these approaches has its strength and limitations; however, harmonization of research efforts is needed. Ongoing development of evidence-based clinical recommendations will benefit from a series of observational and intervention studies aimed at identification, recruitment, and follow-up of transgender people of different ages, from different racial, ethnic, and socioeconomic backgrounds and with diverse gender identities. SUMMARY: Transgender health research faces challenges that include standardization of lexicon, agreed upon population definitions, study design, sampling, measurement, outcome ascertainment, and sample size. Application of existing and new methods is needed to fill existing gaps, increase the scientific rigor and reach of transgender health research, and inform evidence-based prevention and care for this underserved population.
Assuntos
Pesquisa Biomédica/tendências , Atenção à Saúde , Disparidades nos Níveis de Saúde , Disparidades em Assistência à Saúde , Grupos Minoritários , Saúde das Minorias , Pessoas Transgênero , Transexualidade/terapia , Feminino , Prioridades em Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Masculino , Grupos Minoritários/psicologia , Avaliação das Necessidades , Procedimentos de Readequação Sexual , Pessoas Transgênero/psicologia , Transexualidade/psicologia , Estados UnidosRESUMO
PURPOSE OF REVIEW: Transgender individuals experience unique health disparities but are the subject of little focused health research. This manuscript reviews current literature on transgender medical and mental health outcomes and proposes research priorities to address knowledge gaps. RECENT FINDINGS: Published research in transgender healthcare consists primarily of case reports, retrospective and cross-sectional studies, involving largely European settings. Challenges to US-based transgender health research include a diverse population where no single center has sufficient patient base to conduct clinical research with statistical rigor. Treatment regimens are heterogeneous and warrant study for best practices. Current research suggests increased mortality and depression in transgender individuals not receiving optimal care, and possibly a modest increase in cardiovascular risk related to hormone therapy. Current evidence does not support concerns for hormone-related malignancy risk. SUMMARY: The priorities for transgender medical outcomes research should be to determine health disparities and comorbid health conditions over the life span, along with the effects of mental health, medical, and surgical interventions on morbidity and mortality. Specific outcomes of interest based on frequency in the literature, potential severity of outcome, and patient-centered interest, include affective disorders, cardiovascular disease, malignancies, fertility, and time dose-related responses of specific interventions.
Assuntos
Pesquisa Biomédica , Atenção à Saúde , Prioridades em Saúde , Disparidades em Assistência à Saúde , Grupos Minoritários , Saúde das Minorias , Pessoas Transgênero , Transexualidade/terapia , Comorbidade , Feminino , Necessidades e Demandas de Serviços de Saúde , Disparidades nos Níveis de Saúde , Humanos , Masculino , Grupos Minoritários/psicologia , Avaliação das Necessidades , Fatores de Risco , Procedimentos de Readequação Sexual/efeitos adversos , Pessoas Transgênero/psicologia , Transexualidade/epidemiologia , Transexualidade/psicologiaRESUMO
PURPOSE OF REVIEW: In order to improve transgender individuals' access to healthcare, primary care physicians and specialists alike should be knowledgeable about transgender medicine. This review is intended to provide concise transgender hormone treatment guidelines. RECENT FINDINGS: Transgender individuals report that the lack of knowledgeable providers represents the greatest barrier to transgender medical care. Hormone treatments are generally well tolerated and greatly benefit transgender patients. After physicians recognize that gender identity is stable, hormone treatments for transgender patients are often straightforward. A practical target for hormone therapy for transgender men (female to male) is to increase testosterone levels to the normal male physiological range (300-1000 ng/dl) by administering testosterone. A practical target for hormone therapy for transgender women (male to female) is to decrease testosterone levels to the normal female range (30-100 ng/dl) without supra-physiological levels of estradiol (<200 pg/ml) by administering an antiandrogen and estrogen. Patients should be monitored every 3 months for the first year and then every 6-12 months for hormonal effects. SUMMARY: Although more studies are required, recently published transgender medical treatment guidelines provide a good start toward making care of transgender patients more generalized and accessible to healthcare providers.